Contineum Therapeutics, Inc. Class A Common Stock beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.46 | — | — | Miss |
| Q1 FY2026 | $-0.55 | — | — | Miss |
| Q12026 FY2026 | $-0.55 | $-0.39 | +29.1% | Beat |
| 2026-03-05 | $-0.50 | — | — | Miss |
Back to CTNM overview · CTNM holders · CTNM KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.